$PL

Robinson Kristen sold $930K of PL (indirect holdings)

Robinson Kristen sold 37,107 indirectly-held shares of Planet Labs PBC (PL) at $25.05 ($0.93M total) on 2026-07-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Robinson Kristen
Published Jul 16, 2026, 8:11 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 16, 2026, 8:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$PL
Neutral
high confidence
Mentioned
$PL
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PLNeutralLow
01

Why it matters

The newest fact is the disclosed open-market sale of 37,107 shares at $25.0529/share, totaling $929,637.96, with holdings after the sale of 222,897 shares.

02

Market read

Traders may note the insider sale for sentiment, but the 10b5-1 structure suggests limited fundamental information content.

03

What to watch

The sale is indirect and under a pre-arranged plan; without additional context (e.g., total insider activity trend), the signal is likely weak.

Relevance 4/10Novelty 3/10Timing: Filed on 2026-07-16, transaction dated 2026-07-15.

Background

The article is a SEC Form 4 insider transaction disclosure for Planet Labs PBC, reported by director Robinson Kristen.

Company-level read

Ticker impact

$PLNeutralHigh confidence
Context

Planet Labs PBC director Robinson Kristen sold 37,107 shares in an open-market transaction worth about $929,638 under a 10b5-1 plan.

Expected impact

Likely minimal immediate price impact; any effect would be sentiment-driven and short-lived.

Evidence & confidence

The filing is a Form 4 insider transaction, but it is explicitly tied to a pre-arranged 10b5-1 plan, reducing the likelihood of new, time-sensitive negative information.

Market effects

No clear sector read-through from a single director 10b5-1 sale.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated insider selling can still coincide with periods of weaker outlook or liquidity needs, so some traders may treat it as a mild negative sentiment input.

Key entities

  • Planet Labs PBC

    Company whose director insider transaction is disclosed on Form 4.

  • Robinson Kristen

    Director who executed an open-market sale under a Rule 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PLMed

Planet Labs PBC Q2 2027 Earnings Call Summary

Planet Labs PBC reported Q2 2027 revenue growth of 58% YoY, driven by Satellite Services and Defense sectors. Non-GAAP gross margins reached 59%. The company increased CapEx guidance to $100M-$115M for next-gen constellations and maintains $850M in cash. Management highlighted a $4B pipeline for Satellite Services and strategic expansion in Europe.

$PLHighAI 8/10

Planet Labs Shares Jump After Q2 Results Beat Expectations

Planet Labs (PL) reported Q2 2027 revenue of $116.1M, up 58% YoY, beating estimates. Adjusted EPS was $0.02, surpassing expectations. Defense and intelligence revenue rose 90% YoY. The company raised FY2027 revenue guidance to $430M-$441M. Shares rose 14.1% in pre-market trading.

$PLHighAI 8/10

Planet Labs Rallies 10% as Record Revenue Overrides Soft Q3 Guidance

Planet Labs (PL) stock rose 10% after reporting Q2 revenue of $116.1M, beating estimates by 11%, and adjusted EPS of $0.02, reversing a pre-earnings decline. Despite softer Q3 guidance, the company highlights a $4B sovereign satellite-services pipeline. Defense and intelligence revenue grew over 90% YoY, and non-GAAP gross margin was 59%.